Medifast, Inc. (LON:0K05)
| Market Cap | 83.08M |
| Revenue (ttm) | 319.67M |
| Net Income (ttm) | 184.50K |
| Shares Out | n/a |
| EPS (ttm) | 0.01 |
| PE Ratio | 450.31 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 810 |
| Average Volume | 574 |
| Open | 10.62 |
| Previous Close | 10.72 |
| Day's Range | 10.55 - 10.62 |
| 52-Week Range | 10.55 - 22.25 |
| Beta | 0.50 |
| RSI | 23.85 |
| Earnings Date | Nov 3, 2025 |
About Medifast
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and sou... [Read more]
Financial Performance
In 2024, Medifast's revenue was $602.46 million, a decrease of -43.80% compared to the previous year's $1.07 billion. Earnings were $2.09 million, a decrease of -97.90%.
Financial numbers in USD Financial StatementsNews
Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference
BALTIMORE--(BUSINESS WIRE)--Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the charge in addressing the growing health crisis ...
Medifast's Q3 Loss Wider Than Expected, Sales Decline 36% Y/Y
MED's third-quarter results reflect pressure from fewer active OPTAVIA Coaches, but it is steering toward metabolic health for growth.
Medifast Inc (MED) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
Medifast Inc (MED) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic Innovations
Q3 2025 Medifast Inc Earnings Call Transcript
Q3 2025 Medifast Inc Earnings Call Transcript
Medifast outlines Q4 2025 revenue guidance of $65M–$80M amid strategic shift to metabolic health solutions
Medifast, Inc. (MED) Q3 2025 Earnings Call Transcript
Medifast, Inc. (MED) Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsSteven Zenker - Vice President of Investor RelationsDaniel Chard...
Medifast, Inc. 2025 Q3 - Results - Earnings Call Presentation
Medifast Inc Q3 2025 Earnings: EPS of -$0.21 Beats Estimate, Revenue of $89. ...
Medifast Inc Q3 2025 Earnings: EPS of -$0.21 Beats Estimate, Revenue of $89.4M Surpasses Expectations
Medifast (MED) Projects Q4 Revenue Between $65M and $80M
Medifast (MED) Projects Q4 Revenue Between $65M and $80M
Medifast (MED) Reports Q3 Revenue Slightly Below Expectations
Medifast (MED) Reports Q3 Revenue Slightly Below Expectations
Medifast Announces Third Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended Septem...
Medifast (MED) Q3 Earnings Preview: Analysts Expect a Decline
Medifast (MED) Q3 Earnings Preview: Analysts Expect a Decline
Medifast Q3 2025 Earnings Preview
Get the latest Medifast (MED) Q3 earnings preview, analyst projections, and historical beat rates.
Earnings Outlook For Medifast
Medifast (NYSE: MED) is gearing up to announce its quarterly earnings on Monday, 2025-11-03. Here's a quick overview of what investors should know before the release. Analysts are estimating that Med...
Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today announced a strategic transformation, unveiling a n...
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quar...
Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes
BALTIMORE--(BUSINESS WIRE)--With more than 90% of U.S. adults classified as metabolically unhealthy1, the silent crisis of metabolic dysfunction continues to escalate. This condition can be linked to ...
Medifast signals limited use of promotions and unveils Premier+ pricing to drive coach retention
Medifast, Inc. (MED) Q2 2025 Earnings Call Transcript
Medifast (MED) Q2 Revenue Falls 37%
Medifast GAAP EPS of $0.22 beats by $0.41, revenue of $105.6M beats by $3.8M
Medifast Announces Second Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter...
Medifast (MED) Earnings Report: Anticipated Decline in Q2 Performance
Medifast (MED) Earnings Report: Anticipated Decline in Q2 Performance
Medifast Q2 2025 Earnings Preview
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quart...